Every year sees 60,000 more Cambodians infected with tuberculosis. The high prevalence of TB in Cambodia is pushing MSF to innovate.

More >

For patients in Armenia who did not respond to the treatment available for multidrug-resistant tuberculosis (MDR-TB) there were simply no more treatment options before 2013.

More >

Marta is receiving bedaquilin and impenem for her extensively drug-resistant tuberculosis (XDR-TB) in Yerevan, Armenia. These are not new drugs but they are newly available in Armenia and can make treatment more effective. But, says TB doctor Hakob Atsheyan, "you can say this is a last chance."

More >

 
Broyan, an inmate at Yerevan prison in Armenia, takes 13 pills and gets two injections every day for his extensively drug-resistant tuberculosis (XDR-TB). "I am optimistic because I can feel the difference," he says. "I think I will be cured." 
 
Doctors Without Borders/Médecins Sans Frontières (MSF) treated nearly 30,000 TB patients in 2013 in 90 projects around the world.

More >

Seventeen-year-old Tatev has multidrug-resistant tuberculosis (MDR-TB) and takes 14 pills every day. The arduous treatment for MDR-TB is psychologically difficult for everyone, but it can be especially hard for someone Tatev's age. In addition to medical treatment, MSF provides her with emotional counseling. "I've forced myself to believe the treatment will work, and that I'll get rid of TB," she says. "That's my dream."
 

More >

 
Watch a series of short videos about some of the current medical activities of Doctors Without Borders/Médecins Sans Frontières (MSF). 
 
Central African Republic: Health Care Amidst the Violence
Chad and Cameroon: Exodus of Central Africans
Tuberculosis: Hope for Drug-Resistant Patients
Displaced Women: A Double Challenge
Afghanistan: Between Rhetoric and Reality

More >